Zenotech Laboratories Limited (ZENOTECH.BO)
INR 60.97
(0.94%)
INR 60.97
(0.94%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -196.85 Million INR | -76.67% |
| 2022 | -111.42 Million INR | -410.79% |
| 2021 | 35.85 Million INR | -80.3% |
| 2020 | 181.98 Million INR | 3.55% |
| 2019 | 175.74 Million INR | 149.5% |
| 2018 | 70.43 Million INR | 134.11% |
| 2017 | -206.51 Million INR | -138.39% |
| 2016 | 537.95 Million INR | -0.09% |
| 2015 | 538.44 Million INR | 10.96% |
| 2014 | 485.25 Million INR | 17.39% |
| 2013 | 413.37 Million INR | 131.4% |
| 2012 | 178.63 Million INR | 275.09% |
| 2011 | 47.62 Million INR | 428.64% |
| 2010 | -14.49 Million INR | 77.51% |
| 2009 | -64.44 Million INR | -4062494.55% |
| 2008 | -1586.40 INR | 61.71% |
| 2007 | -4143.26 INR | -224.91% |
| 2006 | 3316.95 INR | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -19.03 Million INR | -109.67% |
| 2024 Q1 | 196.85 Million INR | 200.0% |
| 2023 Q2 | -153.08 Million INR | -237.39% |
| 2023 Q3 | 153.08 Million INR | 200.0% |
| 2023 FY | -196.85 Million INR | -76.67% |
| 2023 Q4 | -196.85 Million INR | -228.59% |
| 2023 Q1 | 111.42 Million INR | 200.0% |
| 2022 Q3 | 83.78 Million INR | 200.0% |
| 2022 Q2 | -83.78 Million INR | -446.97% |
| 2022 FY | -111.42 Million INR | -410.79% |
| 2022 Q1 | 24.14 Million INR | -32.65% |
| 2022 Q4 | -111.42 Million INR | -232.98% |
| 2021 Q1 | 24.57 Million INR | -86.5% |
| 2021 FY | 35.85 Million INR | -80.3% |
| 2021 Q4 | 35.85 Million INR | 14.15% |
| 2021 Q3 | 31.4 Million INR | -64.55% |
| 2021 Q2 | 88.59 Million INR | 260.47% |
| 2020 FY | 181.98 Million INR | 3.55% |
| 2020 Q2 | 198.68 Million INR | 0.0% |
| 2020 Q3 | 8.26 Million INR | -95.84% |
| 2020 Q4 | 181.98 Million INR | 2102.41% |
| 2019 Q4 | 175.74 Million INR | -5.25% |
| 2019 Q2 | 117.3 Million INR | -11.48% |
| 2019 Q3 | 185.48 Million INR | 58.12% |
| 2019 Q1 | 132.52 Million INR | 88.14% |
| 2019 FY | 175.74 Million INR | 149.5% |
| 2018 Q3 | 162.68 Million INR | 234.01% |
| 2018 Q1 | 291.6 Million INR | 241.2% |
| 2018 FY | 70.43 Million INR | 134.11% |
| 2018 Q4 | 70.43 Million INR | -56.7% |
| 2018 Q2 | -121.39 Million INR | -141.63% |
| 2017 Q4 | -206.51 Million INR | -144.07% |
| 2017 Q2 | -307.22 Million INR | -4637.99% |
| 2017 Q1 | 6.77 Million INR | -98.74% |
| 2017 FY | -206.51 Million INR | -138.39% |
| 2017 Q3 | 468.56 Million INR | 252.52% |
| 2016 Q1 | 4.47 Million INR | -99.17% |
| 2016 FY | 537.95 Million INR | -0.09% |
| 2016 Q4 | 537.95 Million INR | 1.35% |
| 2016 Q3 | 530.8 Million INR | 3.66% |
| 2016 Q2 | 512.08 Million INR | 11343.2% |
| 2015 Q4 | 538.44 Million INR | 3483.17% |
| 2015 FY | 538.44 Million INR | 10.96% |
| 2015 Q1 | 57.9 Million INR | -88.07% |
| 2015 Q2 | 497.29 Million INR | 758.85% |
| 2015 Q3 | 15.02 Million INR | -96.98% |
| 2014 FY | 485.25 Million INR | 17.39% |
| 2014 Q2 | 429.51 Million INR | 0.0% |
| 2014 Q4 | 485.25 Million INR | 0.0% |
| 2013 Q2 | 286.3 Million INR | 0.0% |
| 2013 FY | 413.37 Million INR | 131.4% |
| 2013 Q4 | 413.37 Million INR | 0.0% |
| 2012 Q4 | 178.63 Million INR | 0.0% |
| 2012 FY | 178.63 Million INR | 275.09% |
| 2012 Q2 | -26.52 Million INR | 0.0% |
| 2011 FY | 47.62 Million INR | 428.64% |
| 2010 FY | -14.49 Million INR | 77.51% |
| 2009 FY | -64.44 Million INR | -4062494.55% |
| 2008 FY | -1586.40 INR | 61.71% |
| 2007 FY | -4143.26 INR | -224.91% |
| 2006 FY | 3316.95 INR | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Sunil Healthcare Limited | 625.4 Million INR | 131.477% |
| ANG Lifesciences India Limited | 671.01 Million INR | 129.337% |
| BDH Industries Limited | -164.47 Million INR | -19.692% |
| Deccan Health Care Limited | -7.07 Million INR | -2682.038% |
| DECIPHER LABS LIMITED | -93.13 Million INR | -111.361% |
| Gujarat Themis Biosyn Limited | -53.88 Million INR | -265.335% |
| Hindustan Bio Sciences Limited | 25.21 Million INR | 880.765% |
| Ishita Drugs and Industries Limited | -48.09 Million INR | -309.283% |
| Jenburkt Pharmaceuticals Limited | -791.91 Million INR | 75.142% |
| KIMIA BIOSCIENCES LIMITED | 431.72 Million INR | 145.598% |
| MedPlus Health Services Limited | 8.67 Billion INR | 102.268% |
| Patidar Buildcon Limited | 25.12 Million INR | 883.479% |
| Add-Shop E-Retail Limited | 116.24 Million INR | 269.342% |
| Bacil Pharma Limited | 569 Thousand INR | 34697.012% |
| Beryl Drugs Limited | 48.7 Million INR | 504.157% |
| Cian Healthcare Limited | 544.97 Million INR | 136.122% |
| Concord Drugs Limited | 164.48 Million INR | 219.679% |
| Sanjivani Paranteral Limited. | -85.95 Million INR | -129.037% |
| Gujarat Terce Laboratories Limited | 37.76 Million INR | 621.282% |
| Sastasundar Ventures Limited | -297.24 Million INR | 33.774% |
| SHAMROCK INDUSTRIAL CO.LTD. | -9.31 Million INR | -2014.468% |
| Source Natural Foods and Herbal Supplements Limited | -58.58 Million INR | -236.014% |
| SUDARSHAN PHARMA INDUSTRIES LI | 1.04 Billion INR | 118.803% |
| Syschem (India) Limited | 3.53 Million INR | 5673.528% |
| Medi-Caps Limited | -3.21 Million INR | -6024.984% |
| Parmax Pharma Limited | 51.8 Million INR | 479.96% |
| Smruthi Organics Limited | 111.28 Million INR | 276.888% |
| Phaarmasia Limited | -4.89 Million INR | -3919.951% |
| Transchem Limited | -3.16 Million INR | -6123.743% |
| Trinity League India Limited | -12 Thousand INR | -1640375.0% |
| Tyche Industries Limited | -788.94 Million INR | 75.048% |
| Vista Pharmaceuticals Limited | 78.7 Million INR | 350.123% |
| Zenith Healthcare Limited | -25.45 Million INR | -673.292% |
| Chemo Pharma Laboratories Limited | -6.05 Million INR | -3149.538% |
| Colinz Laboratories Limited | -64.3 Million INR | -206.14% |
| Denis Chem Lab Limited | -236.28 Million INR | 16.687% |
| Kwality Pharmaceuticals Limited | 921.75 Million INR | 121.357% |
| Makers Laboratories Limited | 172.59 Million INR | 214.06% |
| Panchsheel Organics Limited | -157.82 Million INR | -24.734% |
| Parnax Lab Limited | 787.61 Million INR | 124.994% |
| PRAVEG LIMITED | -434.98 Million INR | 54.744% |
| Mercury Laboratories Limited | -26.72 Million INR | -636.492% |
| Trident Lifeline Limited | 117.56 Million INR | 267.452% |
| Vikram Thermo (India) Limited | 38.62 Million INR | 609.662% |
| Vivanza Biosciences Limited | 50.02 Million INR | 493.509% |
| Zenlabs Ethica Limited | 139.54 Million INR | 241.07% |
| SHELTER PHARMA LIMITED | -44.62 Million INR | -341.146% |
| Vasundhara Rasayans Limited | -76.15 Million INR | -158.502% |
| Bharat Immunologicals & Biologicals Corporation Limited | 689.39 Million INR | 128.555% |
| Roopa Industries Limited | 216.01 Million INR | 191.131% |
| PANJON LTD. | -12.8 Million INR | -1436.985% |
| Pharmaids Pharmaceuticals Limited | 37.28 Million INR | 627.937% |
| TIAAN CONSUMER LIMITED | 13.44 Million INR | 1564.165% |
| Anuh Pharma Limited | -69.8 Million INR | -182.002% |
| Crestchem Limited | -1.45 Million INR | -13476.345% |
| Emmessar Biotech & Nutrition Limited | -60.73 Million INR | -224.14% |
| Sandu Pharmaceuticals Limited | -11.43 Million INR | -1622.283% |
| Fredun Pharmaceuticals Limited | 1.04 Billion INR | 118.856% |
| Trimurthi Limited | -1.17 Million INR | -16608.284% |
| Shukra Pharmaceuticals Limited | -68.26 Million INR | -188.372% |
| Norris Medicines Limited | 214.86 Million INR | 191.62% |
| Veerhealth Care Limited | -2.38 Million INR | -8153.962% |
| Lactose (India) Limited | 373.97 Million INR | 152.64% |
| OXYGENTA PHARMACEUTICAL LIMITE | 571.32 Million INR | 134.456% |
| Ambalal Sarabhai Enterprises Limited | 132.1 Million INR | 249.021% |
| Gennex Laboratories Limited | -552.54 Million INR | 64.373% |
| Godavari Drugs Limited | 530.02 Million INR | 137.141% |
| Shree Ganesh Remedies Limited | 201.85 Million INR | 197.523% |
| Bharat Parenterals Limited | 1.48 Billion INR | 113.223% |
| Coral Laboratories Limited | -612.82 Million INR | 67.877% |
| Evoq Remedies Limited | 41.14 Million INR | 578.412% |
| Kerala Ayurveda Limited | 447.82 Million INR | 143.958% |
| KOBO BIOTECH LIMITED | 1.39 Billion INR | 114.111% |
| Natural Capsules Limited | 956.68 Million INR | 120.577% |
| Auro Laboratories Limited | 252.51 Million INR | 177.958% |